June 30, 2022
The volume-based generic utilization rate in Japan stood at 79.5% in FY2021 ended March 2022, virtually flat from 79.4% logged in FY2020, according to data released by the Japan Generic Medicines Association (JGA) on June 29. The rate represents the...read more